ASPG and acute lymphoblastic leukemia: To assess the prevalence of thrombotic events and their associated factors in patients with ALL treated with L‐asparaginase‐containing regimens in Tikur Anbessa Specialized Hospital (TASH) from November 2020 to November 2023.